<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35481427</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2162-397X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Adipocyte</Title>
          <ISOAbbreviation>Adipocyte</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Adipose tissue from subjects with type 2 diabetes exhibits impaired capillary formation in response to GROα: involvement of MMPs-2 and -9.</ArticleTitle>
        <Pagination>
          <StartPage>276</StartPage>
          <EndPage>286</EndPage>
          <MedlinePgn>276-286</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21623945.2022.2070949</ELocationID>
        <Abstract>
          <AbstractText>Type 2 Diabetes (T2D) is associated with impaired vascularization of adipose tissue (AT) . IL8, GROα and IL15 are pro-angiogenic myokines, secreted at elevated levels by T2D myotubes. We explored the direct impact of these myokines on AT vascularization. AT explants from subjects with T2D and without diabetes (non-diabetic, ND) were treated with rIL8, rGROα and rIL15 in concentrations equal to those in conditioned media (CM) from T2D and ND myotubes, and sprout formation evaluated. Endothelial cells (EC) were isolated from T2D and ND-AT, treated with rGROα and tube formation evaluated. Finally, we investigated the involvement of MMP-2 and -9 in vascularization. ND and T2D concentrations of IL8 or IL15   caused similar stimulation of sprout formation in ND- and T2D-AT. GROα exerted a similar effect in ND-AT. When T2D-AT explants were exposed to GROα, sprout formation in response to T2D concentrations was reduced compared to ND. Exposure of EC from T2D-AT to GROα at T2D concentrations resulted in reduced tube formation. Reduced responses to GROα in T2D-AT and EC were also seen for secretion of MMP-2 and -9. The data indicate that skeletal muscle can potentially regulate AT vascularization, with T2D-AT having impairments in sensitivity to GROα, while responding normally to IL8 and IL15.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Amir Levy</LastName>
            <ForeName>Yifat</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Medicine, University of California, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>P Ciaraldi</LastName>
            <ForeName>Theodore</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Medicine, University of California, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>R Mudaliar</LastName>
            <ForeName>Sunder</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Medicine, University of California, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>A Phillips</LastName>
            <ForeName>Susan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics, University of California, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>R Henry</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Medicine, University of California, La Jolla, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Adipocyte</MedlineTA>
        <NlmUniqueID>101567863</NlmUniqueID>
        <ISSNLinking>2162-3945</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019409">Interleukin-15</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.24.24</RegistryNumber>
          <NameOfSubstance UI="D020778">Matrix Metalloproteinase 2</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019409" MajorTopicYN="N">Interleukin-15</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016209" MajorTopicYN="N">Interleukin-8</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020778" MajorTopicYN="N">Matrix Metalloproteinase 2</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">MMPs</Keyword>
        <Keyword MajorTopicYN="N">Type 2 diabetes</Keyword>
        <Keyword MajorTopicYN="N">adipose tissue</Keyword>
        <Keyword MajorTopicYN="N">angiogenesis</Keyword>
        <Keyword MajorTopicYN="N">groα</Keyword>
        <Keyword MajorTopicYN="N">myokines</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>8</Hour>
          <Minute>34</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35481427</ArticleId>
        <ArticleId IdType="pmc">PMC9116416</ArticleId>
        <ArticleId IdType="doi">10.1080/21623945.2022.2070949</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>DeFronzo RA.
Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: a balanced overview. Diabetologia. 1992;35:389–397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1516769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manneras-Holm L, Krook A. Targeting adipose tissue angiogenesis to enhance insulin sensitivity. Diabetologia. 2012;55:2562–2564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3433656</ArticleId>
            <ArticleId IdType="pubmed">22842613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gealekman O, Guseva N, Hartigan C, et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation. 2011;123:186–194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3334340</ArticleId>
            <ArticleId IdType="pubmed">21200001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017;127:74–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5199684</ArticleId>
            <ArticleId IdType="pubmed">28045400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gealekman O, Guseva N, Gurav K, et al. Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycemic humans in a randomized controlled trial. Diabetologia. 2012;55:2794–2799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3549462</ArticleId>
            <ArticleId IdType="pubmed">22847059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding H, Triggle CR. Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium. 2005;Vasc Health Risk Management. 1:55–71.</Citation>
        </Reference>
        <Reference>
          <Citation>Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion and incorporation into vascular structures. Circulation. 2002;106:2781–2786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12451003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonner JS, Lantier L, Hasenour CM, et al. Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance. Diabetes. 2013;62:572–580.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3554359</ArticleId>
            <ArticleId IdType="pubmed">23002035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spencer M, Unal R, Zhu B, et al. Adpose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab. 2011;96:E1990–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3232606</ArticleId>
            <ArticleId IdType="pubmed">21994960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcus MS, Wong GW. Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines. Adipocyte. 2012;1:200–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3609113</ArticleId>
            <ArticleId IdType="pubmed">23700534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedersen BK, Febbraio MA. Muscle, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22473333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eckel J. Myokines in metabolic homeostasis and diabetes. Diabetologia. 2019;62:1523–1528.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31263909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimberg A. Chemokines in angiogenesis. Curr Top Microbiol Immunol. 2010;341:59–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20373091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ciaraldi TP, Ryan AJ, Mudaliar SR, et al. Altered myokine secretion is an intrinsic property of skeletal muscle in type 2 diabetes. PLoS ONE. 2016;11:e0158209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4959771</ArticleId>
            <ArticleId IdType="pubmed">27453994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouzakri K, Plomgaard P, Berney T, et al. Bimodal effect on pancreatic ß-cells of secretory products from normal or insulin-resistant human skeletal muscle. Diabetes. 2011;60:1111–1121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3064085</ArticleId>
            <ArticleId IdType="pubmed">21378173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amir-Levy Y, Ciaraldi TP, Mudaliar SR, et al. Excessive secretion of IL-8 by skeletal muscle in type 2 diabetes impairs tube growth: potential role of PI3K and the Tie2 receptor. Am J Physiol Endocrinol Metab. 2015;309:E22–E34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25944879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott E, Bicknell R. The isolation and culture of microvascular endothelium. J Cell Sci. 1993;105:269–273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8408265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellafiore M, Battaglia G, Bianco A, et al. The involvement of MMP-2 and MMP-9 in heart exercise-related angiogenesis. J Trans Med. 2013;11:283.</Citation>
        </Reference>
        <Reference>
          <Citation>Rojas-Rodriguez R, Gealekman O, Kruse ME, et al. Adipose tissue angiogenesis assay. Methods Enzymol. 2014;537:75–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4386572</ArticleId>
            <ArticleId IdType="pubmed">24480342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasarica M, Sereda OR, Redman LM, et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2009;58:718–725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2646071</ArticleId>
            <ArticleId IdType="pubmed">19074987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gealekman O, Corvera S. Adipose tissue angiogenesis: impact on obesity and type 2 diabetes. Biochim Biophys Acta. 2014;1842:463–472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3844681</ArticleId>
            <ArticleId IdType="pubmed">23770388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goossens GH, Bizzarri A, Ventclef N, et al. Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation. 2011;124:67–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21670228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Senger DR, Davis GE. Angiogenesis. Cold Spring Harb Perspect Biol. 2011;3:1–19.</Citation>
        </Reference>
        <Reference>
          <Citation>van Harmelen V, Skurk T, Rohrig K, et al. Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women. Int J Obes Relat Metab Disord. 2003;27(8):889–895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12861228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Severinsen MCK, Pedersen BK. Muscle-Organ crosstalk: the emerging roles of myokines. Endocr Rev. 2020;41:594–609.</Citation>
        </Reference>
        <Reference>
          <Citation>Lillioja S, Young AA, Cutler CL, et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest. 1987;80(2):415–424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC442253</ArticleId>
            <ArticleId IdType="pubmed">3301899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schraufstatter IU, Chung J, Burger M. IL-8 activates endothelial cell CXCR1 and CXCR2 through rho and rac signaling pathways. Am J Physiol Lung Cell Mol Physiol. 2001;280:L1094–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11350788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang D, Wang H, Brown JA, et al. CXCl1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med. 2006;203:941–951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2118273</ArticleId>
            <ArticleId IdType="pubmed">16567391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alkhouri H, Moir LM, Armour JCL, et al. CXCL1 is a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro. Clin Exp Allergy. 44. 2014:381–392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24588865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Alwan LA, Chang Y, Rousseau S, et al. CXCL1 inhibits airway smooth muscle cell migration through the decoy receptor duffy antigen receptor for chemokines. J Immunol. 2014;193:1416–1426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24981451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedersen L, Olsen CH, Pedersen BK, et al. Muscle-derived expression of the chemokine CXCL1 attenuates diet-induced obesity and improves fatty acid oxidation in muscle. Am J Physiol Endocrinol Metab. 2012;302:E831–E40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22275756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nunemaker CS, Chung HG, Verrilli GM, et al. Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function. J Endocrinol. 2014;222:267–276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4135511</ArticleId>
            <ArticleId IdType="pubmed">24928936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sajadi SM, Khoramdelazad H, Hassanshahi G, et al. Plasma levels of CXCL1 (GRO-alpha) and CXCL10 (IP-10) are elevated in type 2 diabetic patients: evidence for the involvement of inflammation and angiogenesis/angiostasis in this disease state. Clin Lab. 2013;59:133–137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23505918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong H, Yuan S, Yang Q, et al. Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy. Mol Vis. 2014;20:1137–1145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4124102</ArticleId>
            <ArticleId IdType="pubmed">25253986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maury E, Ehala-Aleksejev K, Guiot Y, et al. Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab. 2007;293:E656–E65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17578888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tourniaire F, Romier-Crouzet B, Lee JH, et al. Chemokine expression in inflamed adipose tissue is mainly mediated by NF-kB. PLoS ONE. 2013;8:e66515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3688928</ArticleId>
            <ArticleId IdType="pubmed">23824685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellegrinelli V, Rouault C, Rodriguez-Cuenca S, et al. Human adipocytes induce inflammation and atrophy in muscle cells during obesity. Diabetes. 2015;64:3121–3134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25695947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujiwara K, Matsukawa A, Ohkawara S, et al. Functional distinction between CXC chemokines, interlukin-8 (IL-8), and growth related oncogene (GRO)a in neutrophil infiltration. Lab Invest. 2002;82:15–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11796822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hurley JR, Cho H, Sheikh AQ, et al. Nanofiber microenvironment effectively restores angiogenic potential of diabetic endothelial cells. Avd Wound Care. 2014; 3: 717–728.</Citation>
        </Reference>
        <Reference>
          <Citation>Yiu K-H, Tse H-F. Specific role of impaired glucose metabolism and diabetes mellitus in endothelial progenitor cell characteristics and function. Arterioscler Thromb Vasc Biol. 2014;34:1136–1143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24743430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez D, Morrison CJ, Overall CM. Matrix metalloproteinases: what do they not do? new substrates and bioloogical roles identified by murine models and proteomics. Biochim Biophys Acta. 2010;1803(1):39–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19800373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tinahones FJ, Coin-Araguez L, Mayas MD, et al. Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol. 2012;12:12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3507716</ArticleId>
            <ArticleId IdType="pubmed">22999299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sotornik R, Brassard P, Martin E, et al. Update on adipose tissue blood flow regulation. Am J Physiol Endocrinol Metab. 2012;302:E1157–E70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22318953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schlich R, Willems M, Greulich S, et al. VEGF in the crosstalk between human adipocytes and smooth muscle cells: depot-specific release from visceral and perivascular adipose tissue. Mediators Inflamm. 2013;982458.10.1155/2013/982458</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/982458</ArticleId>
            <ArticleId IdType="pmc">PMC3723083</ArticleId>
            <ArticleId IdType="pubmed">23935253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bassols J, Ortega FJ, Moreno-Navarrete JM, et al. Study of the proinflammatory role of human differentiated omental adipocytes. J Cell Biochem. 2009;15:1107–1117.</Citation>
        </Reference>
        <Reference>
          <Citation>Ciaraldi TP, Kolterman OG, Olefsky JM. Mechanism of the post-receptor defect in insulin action in human obesity: decrease in the intrinsic activity of the glucose transport system. J Clin Invest. 1981;68:875–880.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC370874</ArticleId>
            <ArticleId IdType="pubmed">7026616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villaret A, Galitzky J, Decaunes P, et al. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression andf cellular senescence. Diabetes. 2010;59:2755–2766.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2963533</ArticleId>
            <ArticleId IdType="pubmed">20713685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curat CA, Miranville A, Sengenes C, et al. From blood monocyte to adipose tissue resident macrophages. Diabetes. 2004;53:1285–1292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15111498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Srinivasan S, Yeh M, Danzinger EC, et al. Glucose regulates monocyte adhesion through endothelial production of interlukin-8. Circ Res. 2003;92:371–377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12600878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hongpaisan J. Inhibition of contaminating fibroblasts by D-valine in cultures of smooth muscle cells from human myometrium. 2000;Cell Biol Intl. 24:1–7.</Citation>
        </Reference>
        <Reference>
          <Citation>Donovan D, Brown NJ, Bishop ET, et al. Comparison of three in vitro human angiogenesis assays with capillaries formed in vivo. Angiogenesis. 2001;4:113–121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11806243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tamura Y, Watanabe F, Nakatani T, et al. Highly selective and orally active inhibitors of type IV collanenase (MMP-9 and MMP-2): n-sulfonylamino acid derivatives. J Med Chem. 1998;41:640–649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9484512</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
